Organization Overview
Historical Acquisition Tree
Alternative names
Key: Chiesi (10) Acquired (3)
birch allergen (2023 NDA)
cangrelor (kengreal) (2015)
clevidipine (cleviprex) (2008)
deferiprone (ferriprox) (2011)
elapegademase-lvlr (revcovi) (2018)
mannitol (Osmitrol) (2020)
nicardipine (cardene) (1988)
pegunigalsidase alfa (Elfabrio) (2023 NDA)
poractant alfa (curosurf) (1999)
reteplase (Retavase) (1996 NDA)
tobramycin (nebcin) (2012)
velmanase alfa (Lamzede) (2023 NDA)
zileuton (zyflo) (1996 NDA)
Key: Chiesi (13) Acquired (7)
beclomethasone (vanceril) (73 trials)
cangrelor (kengreal) (3 trials)
formoterol (foradil) (60 trials)
glycopyrronium (robinul) (26 trials)
Key: Chiesi (17) Acquired (16)
adapalene (differin) (1 trial)
albuterol (proventil) (4 trials)
alteplase (Activase) (1 trial)
amlodipine (norvasc) (1 trial)
benzoyl peroxide (clearasil) (1 trial)
budesonide (rhinocort) (8 trials)
cabergoline (dostinex) (1 trial)
crizotinib (xalkori) (2 trials)
gentamicin (garamycin) (1 trial)
lanreotide (somatuline depot) (1 trial)
lidocaine (xylocaine) (1 trial)
Key: Chiesi (18) Acquired (24)
alipogene tiparvovec (glybera) (1 trial)
atorvastatin (lipitor) (5 trials)
bevacizumab (avastin) (2 trials)
cyclosporine (sandimmune) (1 trial)
dextromethorphan (delsym) (1 trial)
everolimus (zortress) (1 trial)
fenofibrate (fenoglide) (2 trials)
Key: Chiesi (5) Acquired (4)
Acute Coronary Syndrome (Phase 4)
Acute Lung Injury (Phase 2)
alpha-Mannosidosis (Phase 3)
Alzheimer Disease (Phase 2)
Asthma (Phase 4)
Bronchiectasis (Phase 3)
Bronchopulmonary Dysplasia (Phase 4)
Cognitive Dysfunction (Phase 2)
Croup (Phase 3)
Cystic Fibrosis (Phase 4)
Emphysema (Phase 4)
Exocrine Pancreatic Insufficiency (Phase 2)
Fibrosis (Phase 4)
Foot Ulcer (Phase 2)
Heart Arrest (Phase 4)
Heart Diseases (Phase 1)
Hemophilia A (Phase 2)
Hemophilia B (Phase 2)
Hyperlipoproteinemia Type I (Phase 2)
Hyperplasia (Phase 4)
Hypertension (Phase 3)
Hypoplastic Left Heart Syndrome (Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 2)
Infant, Premature, Diseases (Phase 4)
Infarction (Phase 4)
Kidney Failure, Chronic (Phase 4)
Lung Diseases (Phase 4)
Lung Diseases, Obstructive (Phase 4)
Mannosidase Deficiency Diseases (Phase 3)
Meningitis (Phase 2)
Metabolic Syndrome (Phase 2)
Myocardial Infarction (Phase 4)
Neonatal Abstinence Syndrome (Phase 2)
Obesity (Phase 2)
Osteoporosis (Phase 3)
Osteoporosis, Postmenopausal (Phase 3)
Out-of-Hospital Cardiac Arrest (Phase 4)
Pneumonia (Phase 4)
Pneumonia, Ventilator-Associated (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Pulmonary Eosinophilia (Phase 3)
Pulmonary Fibrosis (Phase 2)
Respiratory Distress Syndrome (Phase 4)
Respiratory Distress Syndrome, Newborn (Phase 4)
Sepsis (Phase 3)
Sinusitis (Phase 3)
ST Elevation Myocardial Infarction (Phase 4)
Substance Withdrawal Syndrome (Phase 2)
Syndrome (Phase 4)
Thrombosis (Phase 3)
Tissue Adhesions (Phase 2)
Toxemia (Phase 3)
Ulcer (Phase 2)